§ 522.1850. Polysulfated glycosaminoglycan.
190 words·~1 min read·
/us/cfr/t21/s§ 522.1850A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Specifications.
(1)Each 1-milliliter
(mL)ampule of solution contains 250 milligrams
(mg)polysulfated glycosaminoglycan.
(2)Each mL of solution packaged in 5-mL ampules or 20-, 30-, or 50-mL vials contains 100 mg polysulfated glycosaminoglycan.
(b)Sponsor. See No. 010797 in § 510.600(c) of this chapter.
(c)Special considerations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
(d)Conditions of use—(1) Horses—(i) Indications for use. For the treatment of noninfectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
(ii)Amount—(A) Intra-articular use (carpal): 250 mg once a week for 5 weeks.
(B)Intramuscular use (carpal and hock): 500 mg every 4 days for 28 days.
(iii)Limitations. Do not use in horses intended for human consumption.
(2)Dogs—(i) Indications for use. For control of signs associated with noninfectious degenerative and/or traumatic arthritis of canine synovial joints.
(ii)Amount. 2 mg per pound of body weight by intramuscular injection twice weekly for up to 4 weeks (maximum of 8 injections). [72 FR 56896, Oct. 5, 2007, as amended at 74 FR 67816, Dec. 21, 2009]
Connections1 cite this
Cited by 1 section
Citation graph
cites case law
§ 522.1850
Polysulfated glycosaminoglycan.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source